Miles Electric Vehicles Announces Investment to Develop Highway Speed Sedan

Miles Electric Vehicles announced today a $15,000,000 investment round led by the Los Angeles based private equity fund, Angeleno Group, with participation from existing investors. Funds will be used to advance the development of the all electric MILES XS500 highway speed sedan, which is powered by an advanced technology lithium-ion powertrain, and to expand its leadership in the low speed electric vehicle market.

“Several years ago we made a commitment to do something meaningful to reduce the effects of global warming and to lower our dependence on foreign oil,” said Miles Rubin, Chairman of Miles Electric Vehicles. “Today, we are pleased to announce this investment from Angeleno Group as part of their commitment to funding clean energy technology companies.”

Headquartered in Santa Monica, California, Miles Electric Vehicles was founded in 2005 by entrepreneur Miles Rubin as an all electric, zero emissions vehicle manufacturer. MILES now successfully markets a line of low speed electric cars and trucks that combine the best of United States built motor and controller technology with the most efficient Chinese manufacturing and advanced battery production.

Daniel Weiss, Managing Partner of Angeleno Group, stated, “We are excited to lead the first institutional financing of Miles Electric Vehicles. The company has entered the global electric vehicle market with an innovative, practical approach combining best of breed U.S. and Chinese automobile and battery technology. Miles Rubin, a seasoned and proven entrepreneur, is building a world class company that we are confident will play a leading role in the growing clean transportation industry.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.